NorthWest Biotherapeutics Inc (NWBO)

[jimmy667]

100% agree these high-risk/high-reward Biotech's have a propensity to flash-over with 10-25x market cap appreciation over about 18 months from when they start the run. Anavex Life Sciences run from below $200 million market cap to peak at over $1.7 billion in a period of 18 months. A year or two prior to that Arrowhead Research flashed over from less than $200 million to over $7.0 billion market cap in less than 18 months. Gene Silencing tech. Arrowhead still has a market cap over $3 billion so might be finished with early stage flashovers in market recognition revaluation.
NWBO addresses a much larger indication/treatment market than Arrowhead therefore might run higher as Arrowhead indicatitions are rare diseases. NWBO could also flashover more quickly and violently to the upside due to certain dynamics it the way NWBO is setting up.